NKTR icon

Nektar Therapeutics
NKTR

Overview Fund Activity

225 hedge funds and large institutions have $692M invested in Nektar Therapeutics in 2022 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 79 increasing their positions, 59 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
225
Holders Change
-12
Holders Change %
-5.06%
% of All Funds
3.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
37
Increased
79
Reduced
59
Closed
45
Calls
$3.92M
Puts
$727K
Net Calls
+$3.19M
Net Calls Change
+$9.71M

Top Buyers

1
BlackRock
BlackRock
New York
$120M
2
First Trust Advisors
First Trust Advisors
Illinois
$29.8M
3
GPP
Great Point Partners
Connecticut
$12M
4
State Street
State Street
Massachusetts
$33.2M
5
AllianceBernstein
AllianceBernstein
Tennessee
$8.86M

Top Sellers

1
CCM
Camber Capital Management
Massachusetts
$0
2
BG
Bellevue Group
Switzerland
$109K
3
Millennium Management
Millennium Management
New York
$0
4
MC
Maverick Capital
Texas
$12.2M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
TPCW
251
TD Private Client Wealth
New York
– -$1.09K -13 Closed
CI
252
Cordant Inc
Oregon
– -$1K -6 Closed
7 8 9 10
11